Metastatic differentiated thyroid carcinoma: Clinicopathological profile and outcome in an iodine deficient area

被引:0
|
作者
Mishra, A
Mishra, SK
Agarwal, A
Das, BK
Agarwal, G
Gambhir, S
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nucl Med, Lucknow 226014, Uttar Pradesh, India
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Reports on metastatic differentiated carcinoma in endemic goiter regions are scarce. The aim of this study was to look into the clinicopathological profile and outcome of patients with metastatic differentiated thyroid carcinoma (DTC) of endemic origin. This was a retrospective study of 28 cases of metastatic DTC out of a total of 140 DTC patients managed between 1990 and June 1999. Demographic data, clinicopathological profile, operative and radioiodine ablation therapy details, and follow-up findings were noted. The overall incidence of distant metastases in our series was 20%. Mean age was 48.5 +/- 12.8 years (32.1% patients were < 45 years). Most metastases were detected synchronously (85.7%) and were multiple, with the skeletal system being the commonly affected site. Out of 22 cases having skeletal metastases, 6 patients were young (< 45 years). Though most patients with skeletal metastases had follicular carcinoma (FTC), 4 cases had papillary thyroid cancer (PTC). Near total or total thyroidectomy was done in 26 cases. Sixteen patients required regional lymph node dissection. Resection of metastases was performed in 9 cases. Histopathological diagnosis was PTC, FTC, and poorly differentiated carcinoma in 32.1%, 50.0%, and 17.9% of cases, respectively. Most patients had good symptomatic palliation following administration of I-131 therapy. In 17.9% of cases there were locoregional recurrences. There was an overall 28.6% mortality. Two patients expired in the perioperative period. Six others died in follow-up (all within 3-9 months). In contrast to iodine sufficient regions, the incidence of metastases was high; the majority of cases had synchronous, symptomatic skeletal metastases. Skeletal metastases were not infrequent even in cases of PTC and in young patients. One-third of the cases were young. Though survival was poor despite aggressive management, significant symptomatic palliation could be achieved in most cases.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [1] Metastatic differentiated thyroid carcinoma: Clinicopathological profile and outcome in an iodine deficient area
    Mishra A.
    Mishra S.K.
    Agarwal A.
    Das B.K.
    Agarwal G.
    Gambhir S.
    World Journal of Surgery, 2002, 26 (2) : 153 - 157
  • [2] Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy
    Liu, Wen
    Jiang, Beibei
    Xue, Jingli
    Liu, Ruijing
    Wei, Yuqing
    Li, Peifeng
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 69
  • [3] Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries
    Huy Gia Vuong
    Kondo, Tetsuo
    Oishi, Naoki
    Nakazawa, Tadao
    Mochizuki, Kunio
    Inoue, Tomohiro
    Tahara, Ippei
    Kasai, Kazunari
    Hirokawa, Mitsuyoshi
    Thong Minh Tran
    Katoh, Ryohei
    CANCER MEDICINE, 2016, 5 (08): : 1883 - 1889
  • [4] Outcome of metastatic, radioactive-iodine refractory differentiated, medullary and anaplastic thyroid carcinoma - A single institution's experience
    Nguyen, Bella
    Fong, Zheng
    Gauci, Richard
    Keyser, Jo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 209 - 209
  • [5] Clinicopathological significance of poorly differentiated thyroid carcinoma
    Nishida, T
    Katayama, S
    Tsujimoto, M
    Nakamura, J
    Matsuda, H
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (02) : 205 - 211
  • [6] Poorly differentiated thyroid carcinoma: a clinicopathological study
    Johari, M.
    Rabade, K.
    Rane, S.
    Mittal, N.
    Bal, M.
    Patil, A.
    VIRCHOWS ARCHIV, 2024, 485 : S125 - S125
  • [7] Differentiated thyroid cancer and outcome in iodine deficiency
    Gyory, F
    Balazs, G
    Nagy, EV
    Juhasz, F
    Mezosi, E
    Szakall, S
    Math, J
    Lukacs, G
    EJSO, 2004, 30 (03): : 325 - 331
  • [8] Concomitant Hyperthyroidism in Patients With Thyroid Carcinoma and the Effects of Iodine Supplementation in an Iodine-Deficient Area
    Omur, Ozgur
    Yazici, Buelent
    Akgun, Ayegul
    Ozcan, Zehra
    Akyildiz, Mahir
    Argon, Murat
    Ozkilic, Hayal
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (11) : 769 - 772
  • [9] The Management of Metastatic Differentiated Thyroid Carcinoma
    Sherman S.I.
    Reviews in Endocrine and Metabolic Disorders, 2000, 1 (3) : 165 - 171
  • [10] Iodine biokinetics and 131I absorbed dose in metastatic differentiated thyroid carcinoma
    Liu, Bin
    Kuang, Anren
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)